作者: Gregory N. Tew , Wenxi Pan , Dahui Liu , Yan Li , Hitesh Thaker
DOI:
关键词: Mycobacterium 、 Mucositis 、 Mycobacterium species 、 Cancer 、 Heparin 、 Microbiology 、 Low molecular weight heparin 、 Biology 、 Immune system
摘要: The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating mammal having microbial infection, mucositis, an ophthalmic otic cancer, Mycobacterium infection; species; modulating immune response in mammal; antagonizing unfractionated heparin, low molecular weight heparin/low heparin derivative.